Clinical Trials

INCB 18424-MA-GD-301: An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant


Research Study Number:
Pro-2017-0554

Short Title:
Rux EAP

Division:
Bone Marrow Transplant

Study Status:
Enrolling